Medtronic PROTECTA XT DR D314DRG, Руководство для клиницистов

Страница: 38 / 508

– Minimize the risk of temporary interference with your cardiac device while going
through the security screening process by not touching metal surfaces around any
screening equipment.
– Do not stop or linger in a walk-through archway; simply walk through the archway at
a normal pace.
– If a hand-held wand is used, ask the security operator not to hold it over or wave it
back and forth over your cardiac device.
– If you have concerns about security screening methods, show your cardiac device
ID card to the security operator, request alternative screening, and then follow the
security operator’s instructions.
2.8 Potential adverse events
The potential adverse events associated with the use of transvenous leads and pacing
systems include, but are not limited to, the following events:
●
acceleration of tachyarrhythmias (caused by device)
●
air embolism
●
bleeding
●
body rejection phenomena, including local tissue reaction
●
cardiac dissection
●
cardiac perforation
●
cardiac tamponade
●
chronic nerve damage
●
constrictive pericarditis
●
death
●
device migration
●
endocarditis
●
erosion
●
excessive fibrotic tissue growth
●
extrusion
●
fibrillation or other arrhythmias
●
fluid accumulation
Medtronic PROTECTA™ XT DR D314DRG
38 Clinician Manual